Related Experiment Videos
Myocardial Ischemia Secondary to Synthetic Cannabinoid (K2) Use in Pediatric Patients
Bradley C Clark1, Justin Georgekutty1, Charles I Berul1
1Division of Cardiology, Children's National Health System, Washington, DC; Department of Pediatrics, George Washington University School of Medicine, Washington, DC.
The Journal of Pediatrics
|July 14, 2015
Abstract:
K2 is a synthetic cannabinoid that has potential cardiovascular side effects, including myocardial ischemia, myocardial infarction, and arrhythmias. Cardiac testing of pediatric patients is often not performed owing to a lack of symptomatology. We report a series of pediatric patients with concern for myocardial ischemia temporally associated with K2 exposure.